Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in pa... von Wick, Antje, Desjardins, Annick, Suarez, Cristina, Forsyth, Peter, Gueorguieva, Ivelina, Burkholder, Tiana, Cleverly, Ann Louise, Estrem, Shawn T., Wang, Shuaicheng, Lahn, Michael M., Guba, Susan C., Capper, David, Rodon, Jordi

Volltext

Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer von Gordon, Alan N, Teneriello, Michael, Janicek, Mike F, Hines, Jeffrey, Lim, Peter C, Chen, M. Dwight, Vaccarello, Luis, Homesley, Howard D, McMeekin, Scott, Burkholder, Tiana L, Wang, Yanping, Zhao, Luping, Orlando, Mauro, Obasaju, Coleman K, Gill, John F, Tai, Datchen F

Volltext

Phase Ib study evaluating safety and pharmacokinetics (PK) of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 monohydrate (LY) when combined... von Suarez, Cristina, Rodon, Jordi, Desjardins, Annick, Forsyth, Peter A. J., Gueorguieva, Ivelina, Cleverly, Ann, Burkholder, Tiana, Desaiah, Durisala, Lahn, Michael M. F., Wick, Wolfgang

Volltext

ACTR-16. PHASE 2 STUDY EVALUATING SAFETY, PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD) AND EFFICACY OF THE ORAL TRANSFORMING GROWTH FACTOR-BETA (TGF-β) RECEPTOR I KINASE INHIBITOR... von Desjardins, Annick, Suarez, Cristina, Forsyth, Peter, Gueorguieva, Ivelina, Cleverly, Ann, Burkholder, Tiana, Desaiah, Durisala, Lahn, Michael M, Guba, Susan C, Wick, Wolfgang, Rodon, Jordi

Volltext

Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy von Gordon, Alan N, Teneriello, Michael, Lim, Peter, Janicek, Mike F, Burkholder, Tiana L, Wang, Yanping, Orlando, Mauro, Obasaju, Coleman K, Gill, John F, Tai, Datchen F

Volltext

Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy von Gordon, Alan N, Teneriello, Michael, Lim, Peter, Janicek, Mike F, Burkholder, Tiana L, Wang, Yanping, Orlando, Mauro, Obasaju, Coleman K, Gill, John F, Tai, Datchen F

Volltext

Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in pa... von Wick, Antje, Desjardins, Annick, Suárez, Cristina, Forsyth, Peter, Gueorguieva, Ivelina, Burkholder, Tiana, Cleverly, Ann Louise, Estrem, Shawn T, Wang, Shuaicheng, Lahn, Michael M, Guba, Susan C, Capper, David, Rodon Ahnert, Jordi, Universitat Autònoma de Barcelona

Volltext bestellen

Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in pa... von Wick, Antje, Desjardins, Annick, Suarez, Cristina, Forsyth, Peter, Gueorguieva, Ivelina, Burkholder, Tiana, Cleverly, Ann Louise, Estrem, Shawn T, Wang, Shuaicheng, Lahn, Michael M, Guba, Susan C, Capper, David, Rodon Ahnert, Jordi, Universitat Autònoma de Barcelona

Volltext bestellen